Application of a Neisseria meningitidis antigen microarray to identify candidate vaccine proteins from a human Phase I clinical trial-Reference-Cited by-同舟云学术

Application of a Neisseria meningitidis antigen microarray to identify candidate vaccine proteins from a human Phase I clinical trial

Published:2022-06 Issue:28 Volume:40 Page:3835-3842
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Chang Chun-Mien,Awanye Amaka M.,Marsay Leanne,Dold Christina,Pollard Andrew J.,Rollier Christine S.,Feavers Ian M.,Maiden Martin C.J.,Derrick Jeremy P.^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference52 articles.

1. Epidemiology and pathogenesis of Neisseria meningitidis;Tzeng;Microb Infect,2000

2. On the mechanisms of conjugate vaccines;Rappuoli;Proc Natl Acad Sci U S A,2019

4. Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Chilean National Committee for Meningococcal Disease;Boslego;Vaccine,1995

5. Immune responses against major outer membrane antigens of Neisseria meningitidis in vaccinees and controls who contracted meningococcal disease during the Norwegian serogroup B protection trial;Wedege;Infect Immun,1998

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Profiling IgG and IgA antibody responses during vaccination and infection in a high-risk gonorrhoea population;Nature Communications;2024-08-07

2. OpcA and PorB are novel bactericidal antigens of the 4CMenB vaccine in mice and humans;npj Vaccines;2023-04-12

3. Recent Progress in Development and Application of DNA, Protein, Peptide, Glycan, Antibody, and Aptamer Microarrays;Biomolecules;2023-03-27